APA (7th ed.) Citation

Dong, L., Cao, Z., Chen, M., Liu, Y., Ma, X., Lu, Y., . . . Han, W. (2024). Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers. Nature Communications, 15(1), 1. https://doi.org/10.1038/s41467-024-51495-3

Chicago Style (17th ed.) Citation

Dong, Liang, et al. "Inhibition of Glycosphingolipid Synthesis with Eliglustat in Combination with Immune Checkpoint Inhibitors in Advanced Cancers." Nature Communications 15, no. 1 (2024): 1. https://doi.org/10.1038/s41467-024-51495-3.

MLA (9th ed.) Citation

Dong, Liang, et al. "Inhibition of Glycosphingolipid Synthesis with Eliglustat in Combination with Immune Checkpoint Inhibitors in Advanced Cancers." Nature Communications, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1038/s41467-024-51495-3.